Litigation Details for Philadelphia Federation of Teachers Health and Welfare Fund v. Allergan, Inc. (E.D.N.Y 2017)
✉ Email this page to a colleague
Philadelphia Federation of Teachers Health and Welfare Fund v. Allergan, Inc. (E.D.N.Y 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-12-19 |
| Court | District Court, E.D. New York | Date Terminated | 2023-08-01 |
| Cause | 15:25 Clayton Act | Assigned To | Nina Gershon |
| Jury Demand | Plaintiff | Referred To | Lois Bloom |
| Patents | 9,248,191 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Philadelphia Federation of Teachers Health and Welfare Fund v. Allergan, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Philadelphia Federation of Teachers Health and Welfare Fund v. Allergan, Inc. (E.D.N.Y 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-12-19 | 1 | 048 patent”), and 8,685,930 (“the ’930 patent”) were all issued in 2014. U.S. Patent No. 9,248,191 (“the…. 1, 2014), and US 9,248,191 (dated Feb. 2, 2016). As of September 8, 2017, Allergan purports to have … was protected by U.S. Patent No. 5,474,979 (the “979 Patent” or “Ding I Patent,”) which issued in 1995…eligible for patent protection under United States law. These patents provide the patent-holders (“Brand…was protected by U.S. Patent No. 4,839,342 (“the °342 Patent”). The ‘342 Patent claimed that, by topically | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
